Tvardi Therapeutics (69C.F) Q2 2025 Earnings

May 13Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-6.49
-4.4
-2.31
-0.23

Details

Expected EPS
-0.52277355
Actual EPS
-2.8774886000000004
Surprise EPS
-2.35
Surprise Percent
-450.43%

Description

⁨Tvardi Therapeutics⁩ (⁦69C.F⁩) has reported earnings of ⁦-2.8774886000000004⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts